Informa Results Presentation Deck
The COVID-19 Pandemic
The COVID-19 Pandemic: 2020/2021
Stability & Security: Widespread lockdowns and COVID
restrictions - focus on preserving the long-term value of our
Brands and Businesses
Colleague Support: Colleague Support Fund, Balanced Working,
Unlimited Volunteering, Colleague Assistance Programme; No
access to furlough or government support
Business Flexibility: Customer Support Fund, Events
Postponement Programme, AllSecure Safety Standard, Virtual
Events programme
Cash Management: £600m+ Cost Management Programme,
Cash Retention Programme
Robust Financing: Debt rescheduling and refinancing, £800m
bond issue, £750m short-term credit, £1bn oversubscribed
equity addition, removal of all Group financial covenants
2022 Annual General Meeting
****
informa
The COVID-19 Pandemic: 2022 into 2023
Stability & Security: Most major in-country restrictions
removed, with business normality returning at pace in North
America, Middle East and Europe
Colleague Support: Combination of vaccines, boosters and
working practices supporting the move to work and live with the
virus;
Business Flexibility: Events Postponement Programme in
Mainland China following targeted closed management
measures in H1 2022; Progressive re-opening now underway.
Cash Management: Deliberate shift to enhanced cash
management processes continuing to deliver benefits
Robust Financing: Net debt effectively zero following Pharma
Intelligence divestment combined with continuing strong cash
generation
OT
5View entire presentation